Ohcanbohtosat - Laurie Besson

One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy Dahkki Laurie Besson, Laurie Besson, Laurie Besson, Laurie Besson, Laurie Besson, Laurie Besson, Emily Charrier, Emily Charrier, Emily Charrier, Emily Charrier, Emily Charrier, Emily Charrier, Lionel Karlin, Omran Allatif, Omran Allatif, Omran Allatif, Omran Allatif, Omran Allatif, Antoine Marçais, Antoine Marçais, Antoine Marçais, Antoine Marçais, Antoine Marçais, Paul Rouzaire, Lucie Belmont, Michel Attal, Christine Lombard, Gilles Salles, Thierry Walzer, Thierry Walzer, Thierry Walzer, Thierry Walzer, Thierry Walzer, Sébastien Viel, Sébastien Viel, Sébastien Viel, Sébastien Viel, Sébastien Viel, Sébastien Viel

Viečča ollesdeavstta

High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors Dahkki Antoine Marçais, Marie Marotel, Sophie Degouve, Alice Koenig, Sébastien Fauteux-Daniel, Annabelle Drouillard, Heinrich Schlums, Sébastien Viel, Laurie Besson, Omran Allatif, Mathieu Bléry, Eric Vivier, Yenan Bryceson, Olivier Thaunat, Thierry Walzer

Viečča ollesdeavstta

Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2 Dahkki Candice Sakref, Alexis Saby, Céline Rodriguez, Maude Ardin, Lyvia Moudombi, Anne-Claire Doffin, Elisa Gobbini, Aurélien Voissiere, Laurie Besson, Léo Laoubi, Jan Böttcher, Stéphane Depil, Margaux Hubert, Nathalie Bendriss-Vermare, Christophe Caux, Jenny Valladeau-Guilemond

Viečča ollesdeavstta

Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion Dahkki Marie Marotel, Marine Villard, Annabelle Drouillard, Issam Tout, Laurie Besson, Omran Allatif, Marine Pujol, Yamila Rocca, Michelle Ainouze, Guillaume Roblot, Sébastien Viel, Melissa Gomez, Veronique Loustaud, Sophie Alain, David Durantel, Thierry Walzer, Uzma Hasan, Antoine Marçais

Viečča ollesdeavstta

MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response Dahkki Christophe Caux, Olivier Tredan, Thomas Duhen, Christine Ménétrier-Caux, Raphael Schneider, Laurie Besson, Isabelle Treilleux, Yenkel Grinberg-Bleyer, Anthony Di Roio, Margaux Hubert, Marion Bossennec, Céline Rodriguez, Guilhem Lalle, Lyvia Moudombi, Cyril Degletagne, Daniel J Campbell, Séverine Metzger

Viečča ollesdeavstta